Premenopausal women with even mild depression have less bone mass than do their nondepressed peers.
Ads by Google
Depression Symptoms Treatment
Nondrug, noninvasive depression treatment helps patients who have tried other options without success.
FDA approved the supplemental New Drug Application for ABILIFY as adjunctive, or add-on, treatment to antidepressant therapy in adults with major depressive disorder.
Young adults who have suffered from depression within the past year are at a higher risk of initiating substance use including cigarette smoking and use of alcohol or illicit drugs. The findings, based on the largest national survey on substance use and health, were reported today by the Substance Abuse and Mental Health Services Administration (SAMHSA).
Military service in a war zone increases service members' chances of developing post-traumatic stress disorder (PTSD), other anxiety disorders, and depression.
Women are more susceptible to mood disorders and depression during hormonal transitions, such as pregnancy, postpartum and perimenopause.
Fabre-Kramer Pharmaceuticals Inc. and GlaxoSmithKline announced that FDA has issued a not approvable letter for the new drug application for gepirone extended-release (ER) tablets.
A synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses.
Rates of depression among full-time workers are highest in personal care and service jobs and food preparation and serving occupations.
Although African Americans are less likely than whites to have a major depressive disorder, when they do, it tends to be more chronic.
Health Department launched a new awareness campaign to help de-stigmatize mental health problems and promote positive coping strategies among young Latinas, who suffer from depression at higher rates than other groups.
The House voted to pass a bill that would authorize grants to study the causes and treatments of postpartum depression and postpartum psychosis.
Depression is disabling a growing proportion of children, but evidence on treatment is disputed
A combination of antidepressant drugs and cognitive behavior therapy is the most effective approach when treating teens suffering from major depressive disorder.
Are antidepressants effective as treatments for mentally ill children and adolescents? Are they harmful? These questions have been the topic of immense public debate and are of considerable public health importance.
To learn more about the role of antidepressants in the treatment of children and adolescents living with mental illnesses, the Child and Adolescent Psychiatry Trials Network (CAPTN) is launching the first independently funded large-scale safety registry to track antidepressant use among youth.
Survey found that 90% of headache sufferers also suffer from symptoms of depression.
A combination of psychotherapy and antidepressant medication appears to be the most effective treatment for adolescents with major depressive disorder.
Decision Resources finds that Forest Laboratories' Lexapro and generics-dominated fluoxetine lead first-line therapy in the treatment of major depression. According to the new report entitled Treatment Algorithms in Major Depression, selective serotonin reuptake inhibitors (SSRIs), which include Lexapro and Prozac, account for 63.6 percent of patients on first-line therapy.
Sscientists have a major new clue as to where the long-pursued binding site for commonly used antidepressants may be on brain cells.
Men in late middle age with depressive symptoms are more likely to leave the labor force than men without such symptoms are.
A bill would authorize $3 million in grants in fiscal year 2008 to study the causes and treatments of postpartum depression and postpartum psychosis.
Enhanced and systematic efforts to identify and treat depression in the workplace significantly improves employee health and productivity, likely leading to lower costs overall for the employer.
Enhanced program for depression treatment appears to reduce symptoms of depression, improve work productivity and be cost-effective for employers.
Medical University of South Carolina announced the results of study examining the effects of VNS Therapy for patients with treatment-resistant depression.
The current threshold for what is considered to be 'clinical depression' is too low, could lead to a diagnosis of depression becoming less credible.
May lead to new therapeutic targets for depression treatment.